In this pilot, hypothesis‐generating observational study, our data suggest that modulation of inflammation in patients with CID is associated with dynamic changes in bone turnover profile and that this is paralleled by changes in CPP and FGF23 metabolism. The gene discussed is FGF23; the disease is combined immunodeficiency.